Next Generation News and Research

RSS

Collaboration between Hamilton Robotics and Illumina creates noninvasive streamlined prenatal testing solution

Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal testing (NIPT).

From Hamilton Process Analytics 14 Apr 2017

International research effort reveals major insights into spread of West African Ebola epidemic

An international effort to analyze the entire database of Ebola virus genomes from the 2013-2016 West African epidemic reveals insights into factors that sped or slowed the rampage and calls for using real-time sequencing and data-sharing to contain future viral disease outbreaks.

12 Apr 2017

Human Vaccines Project, VUMC and Illumina team up to decipher genetic underpinnings of immune system

The Human Vaccines Project and Vanderbilt University Medical Center (VUMC) today announced that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system.

12 Apr 2017

Research finding could offer new way to fight deadly pancreatic cancer

Pancreatic cancer, most frequently pancreatic ductal adenocarcinoma (PDAC), is the most lethal and aggressive of all cancers. Unfortunately, there are not many effective therapies available other than surgery, and that is not an option for many patients.

10 Apr 2017

Genomic Analysis Technologies: Past, Present and Future

In this interview, Jay Flatley, Executive Chairman of Illumina, gives an introduction to Illumina and the next generation genomics tools they provide.

From Pittcon 10 Apr 2017

Illumina introduces fast, highly accurate Veriseq NIPT Solution in the European Union

Illumina, Inc. today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing, including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.

10 Apr 2017

Rutgers scientists reveal structure of TB drug target and identify new inhibitors

Rutgers University scientists have determined the three-dimensional structure of the target of the first-line anti-tuberculosis drug rifampin. They have also discovered a new class of potential anti-tuberculosis drugs that kill rifampin-resistant and multi-drug-resistant tuberculosis bacteria.

7 Apr 2017

Expert encourages cardiologists to continue using conventional drug-eluting stents

In a New England Journal of Medicine editorial published last week, Debabrata Mukherjee, M.D., provides expert commentary on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.

6 Apr 2017

Epigem partners with Northumbria University to develop disposable TB testing kit

Leading micro-engineering company Epigem today announced a new Knowledge Transfer Partnership with Northumbria University to develop a cost-effective tuberculosis (TB) testing kit.

From Epigem Ltd. 6 Apr 2017

Paternal diet affects cognitive skills of offspring, mice study shows

The father's lifestyle affects the cognitive skills of his offspring -- at least in mice. Scientists at the German Center for Neurodegenerative Diseases have now shown that if male rodents are fed a diet rich in folic acid, methionine and vitamin B12, their progeny do not perform well in memory tests.

4 Apr 2017

Pioneering IVF technique offers hope to families with inheritable mitochondrial disorders

Details of a pioneering IVF technique using mitochondrial replacement therapy (MRT) have been revealed, giving hope to those families with inheritable mitochondrial disorders that they may be able to have healthy children in the future.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

Researchers shed light on genome reorganization after fertilization in single-cell mammalian embryo

Using a newly developed method researchers at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences have been able to shed light on the complexity of genome reorganization occurring during the first hours after fertilization in the single-cell mammalian embryo

30 Mar 2017

Bruker announces the launch of the next-generation NMR research platform, AVANCE NEO

At the 58th Experimental Nuclear Magnetic Resonance Conference (www.enc-conference.org), Bruker announces the launch of the AVANCE NEO platform, Bruker’s next-generation NMR electronics console in the AVANCE series. The all new AVANCE NEO surpasses the already very advanced AVANCE III HD by offering even faster control, improved dynamic range and enhanced flexibility and scalability.

From Bruker BioSpin Group 30 Mar 2017

Blood-sucking flies can act as 'flying syringes' to track emergence of new diseases

Blood-sucking flies can act as 'flying syringes' to detect emerging infectious diseases in wild animals before they spread to humans, according to research published in the journal eLife.

28 Mar 2017

Platforms for NMR software for spectrometer control and data analysis announced by Bruker

New Magnetic Resonance Technologies and Applications Open New Frontiers for Biological, Chemical and Materials Research and Routine Analysis in Pharmaceutical and Chemical Industries.

28 Mar 2017

CHLA receives NIH grant for biomedical research training to disadvantaged undergraduate students

Emil Bogenmann, PhD, EdD, at The Saban Research Institute of Children's Hospital Los Angeles, received a five-year renewal grant of $1.3 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to provide biomedical research training to disadvantaged college undergraduates.

27 Mar 2017

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

More women are requesting BRCA gene testing associated with certain types of cancer thanks to increased interest in the procedure.

25 Mar 2017

Chromatrap publishes new article comparing efficiency, sensitivity of native and cross-linked ChIP-seq kits

Chromatrap has published a new article that describes a detailed genome wide comparison of native and crosslinked chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq) using the company's patented solid state spin column technology.

From Chromatrap® - Porvair Sciences Ltd 24 Mar 2017